Overview

We leverage cutting-edge molecular technologies to explore tumour biology, treatment resistance, and disease progression.

Combining Scientific Methods in Ovarian Cancer Research

Ovarian cancer is often diagnosed late and has a high relapse rate. By enrolling a Saudi patient cohort and monitoring plasma samples for circulating tumour DNA over a 5-year period, we aim to create customised assays to detect recurrence early, leading to better management and enhanced survival rates. Our research will also allow the establishment of a Saudi-specific ovarian cancer genomics database, aligning with the Kingdom’s Vision 2030 healthcare goals.

Our Team

Our mission is to bridge scientific discovery and clinical impact.
Abdul Khalid Siraj - 41299
Abdu Khalid Siraj
Senior Scientist / Team Leader
Female Arab
Eman Abdulqadier Abdulrazaq
Post-Doctoral Fellow
Female Arab
Khadija Abdulrahman Alobaisi
Research Associate
Beta Version